Clinical Trials Logo
  1. Home
  2. Scleroderma, Systemic
  3. NCT03559465
  4. Details
NCT03559465 Clinical Trial

Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.

Scleroderma, Systemic Clinical Trial

— SCLERO-LB  

Official title:
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03559465
Other study ID # 2016_63
Secondary ID 2017-A02720-53
Status Recruiting
Phase N/A
First received
Last updated
Start date October 29, 2018
Est. completion date December 2023

Study information
Verified date January 2023
Source University Hospital, Lille
Contact David Launay, MD,PhD
Phone 3 20 44 42 95
Email david.launay@chru-lille.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

B Lymphocytes are thought to play an important role in the pathophysiology of systemic sclerosis. In this study, the profibrosing role of B lymphocytes of patients with systemic sclerosis will be evaluated.

Description:

B Lymphocytes of patients with systemic sclerosis will be assessed in term of interaction with fibroblasts from patients with systemic sclerosis and compared to healthy controls.

Recruitment information / eligibility
Status Recruiting
Enrollment 71
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: patients - systemic sclerosis according to ACR-EULAR 2013 - written consent - available insurance Healthy "blood" and healthy "biopsy" controls - written consent - available insurance Exclusion Criteria: patients - overlap with other connective tissue diseases - immunosuppressants in the past 12 months - corticosteroids =10mg/d - pregnancy or breast feeding Healthy "blood" and healthy "biopsy" controls - systemic sclerosis according to ACR-EULAR 2013 - another connective tissue diseases - immunosuppressants in the past 12 months - corticosteroids =10mg/d - pregnancy or breast feeding - With dysimmune inflammatory diseases (except thyroiditis) - Presenting an infection in progress or within the previous 15 days

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• skin biopsy
A skin biopsy will be performed in 10 patients in the form of 2 punches of 5 mm in the injured area in aseptic condition with a Rodnan score. In this study, 10 skin biopsies are needed, and will be performed on the first 10 patients accepting this biopsy.
Other:
• Blood punction
1 blood punction during the normal pathway of care of the patient. This punction will be used to perform the extraction of B lymphocyte

Locations
Country Name City State
France Hôpital Claude Huriez, CHU Lille

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Fibroblast transcriptomic : myofibroblast signature expression of alpha Smooth Muscle Actin 36 months
Secondary Fibroblast transcriptomic expression of COL1A1, COL1A2, COL3A1 by quantitative RT-PCR 36 months
Secondary Difference in collagen infiltration by PicroSirius red staining between the skin biopsies of the two groups 36 months
Secondary Difference in the inflammatory infiltrate by immunohistological markings between the skin biopsies of the two groups 36 months
See also
  Status Clinical Trial Phase
Completed NCT03965780 - The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED) N/A
Terminated NCT02558543 - Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis Phase 2
Withdrawn NCT01202045 - Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients N/A
Terminated NCT01445821 - Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Phase 3
Recruiting NCT05878717 - A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease Phase 3
Not yet recruiting NCT03610217 - Pragmatic Clinical Trials in Scleroderma N/A
Completed NCT02655640 - The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis N/A
Completed NCT05622578 - Phenotyping of Chronic Pain in Diffused Systemic Scleroderma N/A
Recruiting NCT04804930 - Trichoscopy and Systemic Scleroderma
Completed NCT03675581 - A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Phase 1
Completed NCT03221257 - Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate Phase 2
Recruiting NCT05559580 - A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms Phase 2
Completed NCT00442611 - A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Phase 1/Phase 2
Completed NCT00001330 - Study of Silicone-Associated Connective Tissue Diseases N/A
Completed NCT02597933 - A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis Phase 3
Not yet recruiting NCT05821335 - Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis N/A
Completed NCT00333437 - Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement N/A
Completed NCT00025818 - Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome Phase 3
Not yet recruiting NCT05351060 - Novel Splinting Technique Using 3D Models N/A
Not yet recruiting NCT06256575 - Study of Diosmin-Diosmetin for the Treatment of Digital Ulcers in Systemic Sclerosis N/A